Literature DB >> 19140386

[Quality of life in patients with rosacea].

Małgorzata Salamon1, Jan Chodkiewicz, Anna Sysa-Jedrzejowska, Anna Wozniacka.   

Abstract

Rosacea is a common chronic inflammatory disorder which occurs most often in middle-aged women characterized by symptoms of facial flushing and a spectrum of clinical sings including erythema, telangiectasia, burning, coarseness of skin and an inflammatory papulopustular eruption resembling acne. The aim of the study was to evaluate the quality of life in people with rosacea and healthy controls. Forty people with rosacea and 40 people without skin lesions were the subjects of the study. The quality of life was measured using standard questionnaire SF-36 (Short Form 36 Health Survey). The obtained results revealed that, in comparison to the control group, patients with rosacea presented reduced quality of life in subgroups: general health, vitality, emotional sphere, physical functioning, mental health and bodily pain. Outcomes show that rosacea plays a an important role in patient's quality of life and revealed the need to cooperate with psychologists and support groups.

Entities:  

Mesh:

Year:  2008        PMID: 19140386

Source DB:  PubMed          Journal:  Przegl Lek        ISSN: 0033-2240


  4 in total

Review 1.  Rosacea: new and emerging treatments.

Authors:  Farah A Moustafa; Laura F Sandoval; Steven R Feldman
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

Review 2.  [Rosacea 2009 : new advances in pathophysiology, clinical staging and therapeutic strategies].

Authors:  A Sobottka; P Lehmann
Journal:  Hautarzt       Date:  2009-12       Impact factor: 0.751

3.  Evaluating of life quality in patients with acne vulgaris using generic and specific questionnaires.

Authors:  Reza Ghaderi; Alireza Saadatjoo; Faezeh Ghaderi
Journal:  Dermatol Res Pract       Date:  2013-11-25

4.  The Rosacea-specific Quality-of-Life instrument (RosQol): Revision and validation among Chinese patients.

Authors:  Yuxuan Deng; Qinqin Peng; Sai Yang; Dan Jian; Ben Wang; Yingxue Huang; Hongfu Xie; Ji Li
Journal:  PLoS One       Date:  2018-02-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.